Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
27 Total results for product and free and sample content found
Datamonitor Healthcare
By Jack Allen 09 Apr 2018
Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.
Datamonitor Healthcare
By Jack Allen 20 Mar 2018
Zach McLellan, Jack Allen, and guest analysts Louisa Joseph and Michael Haydock discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including results for Gilead's new HIV flagship product; Biktarvy, and the US approval of the HIV drug Trogarzo, the first for salvage patients.
Medtech Insight
By David Filmore 12 Mar 2018
In this edition of Device Week, Medtech Insight’s Reed Miller, David Filmore and Catherine Longworth look back at the past year and the key trends in US and international product approvals, as well as in M&A activity. They also give their perspectives on what to look forward to in 2018.
Topic Medtech
Datamonitor Healthcare
By Jack Allen 09 Mar 2018
Zach McLellan, Jack Allen, and guest analyst Dan Chancellor discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. Featuring analysis of the Sangamo Therapeutics and Gilead/Kite partnership for allogeneic oncology products & update on Restasis patent disputes.
Topic Company analysis
Datamonitor Healthcare
By Zachary McLellan 19 Feb 2018
Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including a recap of the 2018 BIO CEO conference, Phase IIb results of aramchol in HIV-lipodystrophy NAFLD or NASH patients, and the approval of Ereleada (apalutamide) in non-metastatic castration-resistant prostate cancer.
Datamonitor Healthcare
By Jack Allen 09 Feb 2018
Zach McLellan, Jack Allen, and this weeks guest analyst from London, Ines Mihel, discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a discussion around the announcement of "profit-free" health insurance plans from Amazon, JP Morgan, and Berkshire Hathaway.
Topic Drug approval
Datamonitor Healthcare
22 Jan 2018
Zach McLellan, Jack Allen, and this weeks guest analyst Dustin Phan, discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a discussion of Celgene's potential acquisition of Juno.
Topic Cancer Clinical trials
Datamonitor Healthcare
07 Jan 2018
Zach McLellan and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. This episode of the podcast features a roundtable discussion of potential deals prior to the JPM Healthcare Conference.
Topic Cancer
Datamonitor Healthcare
20 Dec 2017
Zach McLellan, Kevin Shannon and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast including Results from bluebird bio’s anti-BCMA CAR T.
Topic Cancer Clinical trials
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
